Regulation of CD30 antigen expression and its potential significance for human disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma on behalf of the Medicines and Healthcare products Regulatory Agency Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group.British journal of haematology · 2021
   Guideline
2. Breast implant-associated ALCL: a unique entity in the spectrum of CD30+ lymphoproliferative disorders.The oncologist · 2013
   Pooled it
3. Use of Recombinant Chikungunya Virus expressing Nanoluciferase to Identify Chondrocytes as Target Cells in an Immunocompetent Mouse Model.The Journal of infectious diseases · 2025
   Article
4. Complications of Brentuximab Therapy in Patients with Hodgkin's Lymphoma and Concurrent Autoimmune Pathology-A Case Series.Hematology reports · 2024
   Article
5. Brentuximab vedotin induced uveitis.American journal of ophthalmology case reports · 2022
   Article
6. NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target.Cancers · 2021
   Review
7. 3D image analysis reveals differences of CD30 positive cells and network formation in reactive and malignant human lymphoid tissue (classical Hodgkin Lymphoma).PloS one · 2019
   Article
8. CD30 is a potential therapeutic target in malignant mesothelioma.Molecular cancer therapeutics · 2015
   Article
9. High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides.The Journal of investigative dermatology · 2012
   Article
10. CD30+ lymphoproliferative disorders.Haematologica · 2010
    Article
11. Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2007
    Article
12. Human embryonal epithelial cells of the developing small intestinal crypts can express the Hodgkin-cell associated antigen Ki-1 (CD30) in spontaneous abortions during the first trimester of gestation.Theoretical biology & medical modelling · 2005
    Article
13. Ber-H2 (CD30) immunohistochemical staining of human fetal tissues.International journal of biological sciences · 2005
    Article
14. AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.The American journal of pathology · 2003
    Article
15. Hodgkin's lymphoma and CD30 signal transduction.International journal of hematology · 2003
    Review
16. Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor.Journal of endocrinological investigation · 2002
    Article

Corrections and comments

• Comment on
  Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene.2000

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as